CONTINENTAL STRATEGY, LLC

Lobbying for DEXCOM · Healthcare company that develops, manufactures, produces, and distributes CGMs.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · California · $75,000.00 income · posted Jul 18, 2025

Lobbying activity 2

Health Issues

continuous glucose monitoring

Medical/Disease Research/Clinical Labs

continuous glucose monitoring

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.